Schmidt, Thomas S. B. http://orcid.org/0000-0001-8587-4177
Li, Simone S. http://orcid.org/0000-0002-0073-3656
Maistrenko, Oleksandr M. http://orcid.org/0000-0003-1961-7548
Akanni, Wasiu http://orcid.org/0000-0002-2075-2387
Coelho, Luis Pedro
Dolai, Sibasish
Fullam, Anthony
Glazek, Anna M.
Hercog, Rajna http://orcid.org/0000-0003-2587-9739
Herrema, Hilde
Jung, Ferris
Kandels, Stefanie
Orakov, Askarbek http://orcid.org/0000-0001-6823-5269
Thielemann, Roman http://orcid.org/0000-0003-2582-6178
von Stetten, Moritz
Van Rossum, Thea
Benes, Vladimir http://orcid.org/0000-0002-0352-2547
Borody, Thomas J. http://orcid.org/0000-0002-0519-4698
de Vos, Willem M. http://orcid.org/0000-0002-0273-3166
Ponsioen, Cyriel Y.
Nieuwdorp, Max
Bork, Peer http://orcid.org/0000-0002-2627-833X
Article History
Received: 5 October 2021
Accepted: 23 June 2022
First Online: 15 September 2022
Competing interests
: T.J.B. has a pecuniary interest in the Centre for Digestive Diseases in Australia and holds patents in the use of FMT for gastrointestinal diseases. C.Y.P. received funding grants from Gilead and Perspectum, speaker’s fees from Tillotts and consultancy fees from Shire and Pliant. M.N. and W.M.d.V. are founders and members of the Scientific Advisory Board of Caelus Health (the Netherlands). M.N. is a Scientific Advisory Board member of Kaleido Biosciences (USA). W.M.d.V. is founder and Scientific Advisory Board member of A-mansia Biotech (Belgium). These conflicts bear no relevance to the content of this manuscript.